According to the study conducted by Zhao, TRIM32 downregulates p21/p27 and upregulates IAP family proteins to confer cisplatin resistance to BC and facilitate its growth through the NF‐κB signaling pathway.194. Here, TRIM32 is linked to breast cancer.